
Products
Built multiple sets of modular, multi-functional intelligent drug automatic synthesis platform
OnePlatform version 3.1
Keywords: synthetic equipment disposable consumables
Classification:
Synthesis Equipment

Hotline:
OnePlatform version 3.1
Graphic Details
OnePlatform 3.1, as a simple, stable and repeatable standardized drug synthesis system, is suitable for the development of complex radiochemical labeling processes. It has the characteristics of high automation, small volume, and strong stability. At the same time, it realizes the automation of the entire process of drug synthesis, including nuclide leaching, quality control, separation and purification, filtration and sterilization.
OnePlatform3.1 is mainly used for nuclide labeling such as 18F, 11C, 68Ga, 64Cu, and includes the following features:
● Realize the synthesis of small molecule, peptide, protein/antibody labeling functions;
● High design flexibility and strong exploitability;
● Combination modular design, with optional functional modules to achieve multiple functions on the basis of the host;
The company has developed new synthesis processes for various new nuclide labeled positron emission tomography tracers (such as 18F Safranamide, 18F FHBG, 18F MK9470, etc.), which have application value in the mechanism research and diagnosis of major diseases such as tumors, cardiovascular and cerebrovascular diseases, and neurodegeneration. The company's core products include the design and manufacturing of advanced automatic synthesis systems for radioactive drugs, as well as the design, synthesis, and production of PET tracers.
Previous Page
OnePlatform3.1 Advanced Edition
Next Page
Related Products
Consulting